Work

KRAS mutation status critically determines the clinical outcome of patients with KMT2A‐rearranged acute myeloid leukemia

Year: 2025

Type: article

Study design: Observational Study

Source: Cancer

DOI: 10.1002/cncr.35941

Authors: Yibo Wu, Xiaolin Yuan, Xiaoyu Lai, Lizhen Liu, Yue Liang, Luxin Yang, Panpan Zhu, Jimin Shi, Jian Yu, Yanmin Zhao, Weiyan Zheng, Jie Sun, Yuanyuan Zhu, Wenjun Wu, Zhen Cai, He Huang, Shanshan Pei, Yi Luo

Institutions: First Affiliated Hospital Zhejiang University, Zhejiang University, Chinese Academy of Sciences, Zhejiang Cancer Hospital, Hangzhou Institute of Medicine, Chinese Academy of Sciences

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: National Natural Science Foundation of China

Awards: G1374265112, G3569377146

OpenAlex ID: W4411468956

FWCI: 1.925

Cites: 39

Cited by: 3

Related to: 10